Healthcare provider profile · identity verified

David P Johnson, MD

Family Practice · MILWAUKEE, WI · NPI 1235180084

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	245	74
Amlodipine Besylate	Amlodipine Besylate	176	67
Oxycodone Hcl	Oxycodone Hcl	145	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	127	22
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	114	20
Lisinopril	Lisinopril	107	41
Gabapentin	Gabapentin	106	44
Albuterol Sulfate Hfa	Albuterol Sulfate	100	36
Fluticasone Propionate	Fluticasone Propionate	79	21
Duloxetine Hcl	Duloxetine Hcl	78	24
Metformin Hcl	Metformin Hcl	78	24
Tizanidine Hcl	Tizanidine Hcl	74	20
Pantoprazole Sodium	Pantoprazole Sodium	73	26
Furosemide	Furosemide	68	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	64	16
Losartan Potassium	Losartan Potassium	62	26
Pregabalin	Pregabalin	62	11
Jardiance	Empagliflozin	61	17
Tramadol Hcl	Tramadol Hcl	61	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	59	19
Omeprazole	Omeprazole	58	18
Metformin Hcl Er	Metformin Hcl	56	18
Trulicity	Dulaglutide	55	15
Metoprolol Succinate	Metoprolol Succinate	53	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	52	15
Eliquis	Apixaban	47	12
Carvedilol	Carvedilol	44	14
Metoprolol Tartrate	Metoprolol Tartrate	43	suppressed
Mirtazapine	Mirtazapine	42	19
Diclofenac Sodium	Diclofenac Sodium	39	14
Sertraline Hcl	Sertraline Hcl	37	suppressed
Levothyroxine Sodium	Levothyroxine Sodium	36	14
Tamsulosin Hcl	Tamsulosin Hcl	36	suppressed
Trazodone Hcl	Trazodone Hcl	36	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	33	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	suppressed
Spironolactone	Spironolactone	32	12
Suboxone	Buprenorphine Hcl/Naloxone Hcl	32	suppressed
Insulin Lispro Protamine Mix	Insulin Lispro Protamin/Lispro	31	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	30	suppressed
Morphine Sulfate Er	Morphine Sulfate	29	suppressed
Allopurinol	Allopurinol	28	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Ozempic	Semaglutide	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Naproxen	Naproxen	24	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	23	suppressed
Hydrocortisone	Hydrocortisone	22	suppressed
Linzess	Linaclotide	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	21	suppressed
Potassium Chloride	Potassium Chloride	21	suppressed
Aripiprazole	Aripiprazole	20	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Pravastatin Sodium	Pravastatin Sodium	20	suppressed
Topiramate	Topiramate	20	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Entresto	Sacubitril/Valsartan	14	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Clonazepam	Clonazepam	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Simvastatin	Simvastatin	13	suppressed
Clopidogrel	Clopidogrel Bisulfate	12	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	12	suppressed
Famotidine	Famotidine	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Prednisone	Prednisone	12	12
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Xtampza Er	Oxycodone Myristate	12	suppressed
Azithromycin	Azithromycin	11	suppressed
Nystatin	Nystatin	11	suppressed
Sublocade	Buprenorphine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error